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X-linked nonspecific mental retardation (MRX) has a frequency of 0.15% in the male population and is caused
by defects in several different genes on the human X chromosome. Genotype-phenotype correlations in male patients
with a partial nullisomy of the X chromosome have suggested that at least one locus involved in MRX is on
Xp22.3. Previous deletion mapping has shown that this gene resides between markers DXS1060 and DXS1139, a
region encompassing ∼1.5 Mb of DNA. Analyzing the DNA of 15 males with Xp deletions, we were able to narrow
this MRX critical interval to ∼15 kb of DNA. Only one gene, VCX-A (variably charged, X chromosome mRNA
on CRI-S232A), was shown to reside in this interval. Because of a variable number of tandem 30-bp repeats in
the VCX-A gene, the size of the predicted protein is 186–226 amino acids.VCX-A belongs to a gene family containing
at least four nearly identical paralogues on Xp22.3 (VCX-A, -B, -B1, and -C) and two on Yq11.2 (VCY-D, VCY-
E), suggesting that the X and Y copies were created by duplication events. We have found that VCX-A is retained
in all patients with normal intelligence and is deleted in all patients with mental retardation. There is no correlation
between the presence or absence of VCX-B1, -B, and VCX-C and mental status in our patients. These results
suggest that VCX-A is sufficient to maintain normal mental development.
Introduction
X-linked nonspecific mental retardation (MRX [MIM
309530) accounts for ∼25% of mental retardation in
males (Turner and Opitz 1980), which equals ∼0.15%
of the male population (Gedeon et al. 1996; Chelly 1999;
Ge´cz and Mulley 2000). Despite this high frequency,
little is known about the biological basis of this clinical
entity. Patients with MRX have learning disabilities as
a single clinical feature and show no other consistent
abnormalities. During the past few years, positional-
cloning approaches and subsequent mutation analysis
have identified seven different genes involved in the phe-
notype of MRX. These genes include that for oligo-
phrenin (OPHN1), PAK3, GDI1, RPS6KA3, IL1RAPL,
and that for tetraspanin (TM4SF2), all of which have
been shown to participate in various stages of intra-
cellular signaling, and the gene FMR2, the function of
which remains unknown (reviewed in Ge´cz and Mulley
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2000). RPS6KA3, on Xp22.13, has been shown to be
involved in both nonspecific and syndromal (Coffin-
Lowry syndrome) mental retardation (Trivier et al.
1996; Merienne et al. 1999).
Genotype-phenotype correlations in male patients
with a partial nullisomy for the X chromosome have
suggested at least one further MRX locus, distal to the
RPS6KA3 gene. Initial deletion mapping assigned this
putative MRX gene to an interval of ∼3 Mb on Xp22.3
(Ballabio et al. 1989). This assignment was narrowed
to a region between DXS1145 and GS1 (Herrell et al.
1995), between DXS1060 and DXS1139 (Muroya et
al. 1996), and between DXS1060 and GS1 (Weissortel
et al. 1998), with a common overlap of ∼1.5 Mb.
Six disease genes have been mapped to Xp22.3; these
include the genes for short stature (SS), X-linked reces-
sive chondrodysplasia punctata (CDPX), MRX, X-
linked ichthyosis (XLI), Kallmann syndrome (KAL),
and ocular albinism type I (OA1) (Ballabio and Andria
1992). Of these six genes, only the gene for SS resides
within the pseudoautosomal region 1 and is identical
on both the X and the Y chromosomes; the other five
genes have been assigned to the X-specific region and
are inherited as X-linked recessive traits. Extensive po-
sitional-cloning studies have been carried out during the
past 12 years, resulting in the successful cloning of
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Table 1
Primer Sequences and PCR Conditions Established in This Study
LOCUS
PRIMER
(5′r3′)
ANNEALING
TEMPERATURE
(C)
SIZE
(bp)Forward Reverse
DXS6837 attcatcatatatacatcag agtcatactttaatcttgc 62 88
BT47 agccagcgcagcatctatgaa taagtttacttgcccaattcc 58 123
K7-2 tgtcgtgtcgtgtgtgttttacca aaaaaaatggcccagagca 58 393
K2H ctgcagggatctgaggattgt ctggcaccttatgttagaagt 58 186
K6a gtcctgctctaatcagtttctaagtgct tgcagaaatcaaggaggaagtgggag 58 186
K5 ggttgcagaactctgatttagagcatctac caggagctctcatcaagaaagtggg 58 300
DXS6834 ccaatcagagagctcag atctgctcatgcttctc 57 148
VCX EIb tgatggtgcgttgtgacgtataagg cgggccactggggctcggctg 60 281
VCX EIIb aaaccagagcccttctgtgatctcc cttagtcgctgctctcggag 61 Variablec
MAP EII tgtagacggccagctactcc atcttcagaatggcaagcac 61 106
Reverse transcriptase gatgagtccaaagccgagag atcttcagaatggcaagcac 61 Variable
a Positive in all individuals tested (including cases 1–4, which had large deletions of Xp22.3), indicating that this
locus is repetitive.
b “VCX EI” and “VCX EII” indicate specific primers for exon I and exon II of the VCX family, respectively.
c Described in the text.
SHOX (for SS), ARSE (for CDPX), STS (for XLI), KAL
(for KAL), and OA1 (for OA1); however, the gene for
MRX has remained elusive.
We have studied 15 male individuals with rearrange-
ments and specific clinical features of the contiguous
gene–deletion syndrome on Xp22.3 (Ballabio et al.
1989). Comparison between the deletion breakpoints
and the clinical phenotype revealed a critical MRX re-
gion of only 15 kb, in which the small full-length gene
VCX-A (variably charged, X chromosome mRNA on
CRI-S232A) was isolated.
Material and Methods
Deletion Mapping
Genomic DNA was extracted from peripheral blood
leukocytes (cases 1, 6-11, 13, and 511), lymphoblast cell
lines (cases 2–5 and 12), or fibroblast cell lines (case 88)
and was examined by PCR analysis. Primers newly es-
tablished in this study are shown in table 1. The other
primer sequences and conditions have been described
elsewhere (Schaefer et al. 1993; Herrell et al. 1995; Mu-
roya et al. 1996). PCR analysis was carried out at least
three times for each locus. For detailed mapping of the
members of the VCX family, specific primers termed
“MAP EII” were used for PCR, and the resulting frag-
ments were cleaved as described in the “Reverse Tran-
scription–PCR (RT-PCR)” subsection below.
Physical Mapping
Cosmids and plasmid artificial chromosomes (PACs)
were derived from the Imperial Cancer Research Fund
(ICRF) X chromosome–specific library (ICRFc104), the
Lawrence Livermore Laboratory Biology and Biotech-
nology Research Program X chromosome–specific li-
brary (LLNc110), and the Roswell Park Cancer Institute
(RPCI [see the “BACPAC Resources” Web site of the
Children’s Hospital Oakland Research Institute]) human
PAC library (Ioannou et al. 1994). YAC clones were
derived from either the Fondation Jean Dausset CEPH
Human Mega-YAC library or the X chromosome YAC
collection maintained at the Max-Planck Institut for
Molecular Genetics (Berlin) and bacterial artificial chro-
mosome (BAC) clones of the BAC (I) library constructed
by Genome Systems. Clones were identified by PCR, by
means of sequence-tagged sites mapping to this region.
To verify overlaps, end probes from clones were used in
cases in which overlaps could not be proved by use of
known primers.
FISH Analysis
Biotinylated DNA was hybridized to metaphase chro-
mosomes from stimulated lymphocytes of the patients,
under conditions that have been described elsewhere
(Lichter and Cremer 1992). The hybridized probe was
detected via avidin-conjugated FITC.
PCR Amplification
All PCRs were performed in 50-ml volumes containing
100 pg–200 ng of template, 20 pmol of each primer,
200 mM of each dNTP (MBI), 1.5 mM MgCl2, 75 mM
Tris/HCl pH 9.0, 20 mM (NH4)2SO4, 0.01% (w/v)
Tween-20, and 2 U of Goldstar DNA polymerase (Eu-
rogentec). Thermal cycling was carried out in a ther-
mocycler GeneE (Techne). PCRs with newly established
primers were carried out under the following conditions:
35 cycles of 93C for 2 min, 93C for 20 s, annealing
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temperature for 20 s, and 72C for 40 s; and 72C for
7 min.
Exon Amplification
The cosmids were partially digested with Sau3A. Gel-
purified fractions in the size range of 4–10 kb were
cloned into the BamHI-digested pSPL3B vector and,
with minor modification, were used for the exon-am-
plification experiments, as described elsewhere (Church
et al. 1994; Burn et al. 1995). The second PCR ampli-
fication was performed with UDG-tailed SA4 and SD2
primers, and the product was cloned in the vector pAMP
system (Gibco-BRL), according to the manufacturer’s
recommendations.
Northern Hybridization
Human adult and fetal multiple-tissue northern-blot
filters (Clontech) were hybridized in ExpressHyb hy-
bridization solution (Clontech) at 65C andwerewashed
at a final stringency of 0.1# SSC, 0.1% SDS. The probe
used for northern hybridization was a PCR product am-
plified with primers VCX EI (forward) and VCX EII
(reverse).
ReverseTranscription–PCR (RT-PCR)
Human poly(A) RNA of liver, heart, kidney, brain,
muscle, stomach, and placenta was purchased from
Invitrogen, and amygdala, thalamus, hippocampus,
and caudate nucleus was purchased from Clontech.
Total RNA was isolated from fetal heart, kidney,
brain, muscle, and testis by TRIZOL reagent (Gibco-
BRL), according to the manufacturer’s recommen-
dations. First-strand cDNA synthesis was performed
with the Superscript first-strand cDNA synthesis kit
(Gibco-BRL), starting with either 20–50 ng of
poly(A) RNA or 10 mg of total RNA and using oligo-
(dT) adaptor primer 5′-GGCCACGCGTCGACTA-
GTAC(dT)20N-3
′. After first-strand cDNA synthesis,
the reaction mix was diluted 1/10. For further PCR
experiments, 5 ml of the dilutions were used. A “Mar-
athon adaptor-ligated ds cDNA library” was con-
structed from poly(A) RNA, with the Marathon
cDNA amplification kit (Clontech) used according to
the manufacturer’s recommendations. RT-PCR was
carried out by performing 40 cycles with primer pairs
shown in table 1. PCR products were digested with
BsmAI (New England Biolabs), RsaI, or AluI (Roche
Diagnostics).
Cloning and Sequencing of PCR Products
PCR products were cloned into the pCR2.1-TOPO
vector (Invitrogen). The clones were sequenced with
Cy5-labeled vector primers M13, universal and re-
verse, by the cycle sequencing method described by
the manufacturer (ThermoSequenase kit; Amersham),
and were analyzed on an ALF-express automated se-
quencer (Pharmacia).
Genomic Sequencing
Mechanically sheared fragments of cosmid ICRFc104-
A05122 and EcoRI/HindIII-digested fragments of cos-
mid LLNc110-45O15were subcloned in pUC18 vectors.
For fragments 13 kb, internally deleted fragments were
generated. Remaining gaps were closed by primer walk-
ing. The sequencing was done via cycle sequencing with
the AmpliTaq S core kit (Applied Biosystems) and stan-
dard forward and reverse primers labeled with either
FITC or CY5. AnMJ Research (Waltham) PT-200 cycler
was used to perform 25 cycles (97C for 15 s, 55C for
30 s, and 68C for 30 s). Reactions were loaded onto
the 72-clone porous-membrane combs, were applied to
60-cm-long polyacrylamide gels (4.5% Hydrolink Long
Ranger gel solution; FMC), and were analyzed by the
ARAKIS sequencing system with array detectors (Erfle
et al. 1997). This system allows simultaneous online se-
quencing on both strands (“doublex” sequencing), with
the two sequencing products obtained in a single se-
quencing reaction, each labeled with a different fluores-
cent dye (Wiemann et al. 1995). Sequencing data were
assembled and edited, by the software packages (i.e.,
LANE TRACKER and GENE SKIPPER) developed by
EMBL.
Results
Defining and Cloning the MRX Critical Region
Fifteen males with terminal and interstitial deletions
of Xp22.3 were analyzed in our study (table 2). Their
mental status was evaluated either with the aid ofWISC-
R or WAIS or on the basis of developmental history.
Cases 1–4 had obvious mental retardation, with devel-
opmental quotient (DQ) or intellectual quotient (IQ) in
the 46–75 range, in addition to other specific clinical
features consistent with the contiguous gene–deletion
syndrome on Xp22.3. Patients 5–13, 88, and 511 had
normal intelligence (defined here as IQ 191) yet one or
more other clinical features (table 2). For the deletion
analysis, individuals with IQ 75–90 were excluded, as
being “borderline” cases (Muroya et al. 1996). To define
the breakpoint regions on the rearranged X chromo-
somes, PCR was performed with primers specific for 25
different loci of the chromosome X–specific region on
Xp22.3. As depicted in figure 1, only patient 13 had a
complex deletion; the other patients had simple terminal
or interstitial deletions. To define the MRX critical in-
terval, individual breakpoints were correlated with the
mental status of the respective cases. All patients with
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Table 2
Cytogenetic and Clinical Findings in 15 Patients with Deletions on Xp22.3
Case Karyotype Clinical Feature(s)a Intellectual Assessment Reference
1 46,XY MR, XLI DQ p 60 Authors’ unpublished data
2 46,Y,der(X)t(X;Y)(p22.3;q12) SS, CDPX, MR, XLI No single words (at age 2 years) Agematsu et al. (1988)
3 46,Y,der(X)t(X;Y)(p22;q11) SS, CDPX, MR, XLI, KAL, (OA1) DQ p 65–75 Nishimura et al. (1991)
4 46,XY (SS), MR, XLI, KAL, OA1 IQ p 46 Muroya et al. (1996)
5 46,Y,der(X)t(X;Y)(p22.3;q11) SS Average (based on school records) Muroya et al. (1996)
6 46,Y,r(X)(p22.3q28) SS, (CDPX) Average (based on school records) Ogata et al. (1990)
7 46,XY XLI Average (based on school records) Authors’ unpublished data
8 46,XY XLI Average (based on school records) Authors’ unpublished data
9 46,XY XLI Average (based on school records) Authors’ unpublished data
10 46,XY XLI Average (based on school records) Authors’ unpublished data
11 46,XY XLI DQ p 110 Authors’ unpublished data
12 46,XY XLI, epilepsy DQ p 103 Authors’ unpublished data
88 46,XY XLI Normal development Schaefer et al. (1993)
13 46,XY SS, CDPX, XLI High (based on school records) Schaefer et al. (1993)
511 46,XY (SS), XLI, KAL Normal development Unpublished
a Parentheses indicate very mild or borderline phenotypes. Clinical reports of all individuals except cases 1, 7–12, and 511
have been published previously.
mental retardation lack a DNA interval including mark-
ers DXS1139 and STS, whereas all individuals with nor-
mal intelligence retain the marker(s) DXS6837 and/or
DXS1139, suggesting that there is an MRX critical re-
gion between DXS6837 and DXS1139.
This critical region was subsequently isolated inYACs,
PACs, and cosmid clones (fig. 2A). PCR analysis of
newly derived sequence-tagged-site markers revealed
that cases 11 and 13, both with normal intelligence,
share only a small region between markers 40BT and
DXS1139. The entire gene for MRX is predicted to be
located in this interval, which is covered by two over-
lapping cosmids, LLNc110-45O15 and ICRFc104-
A05122. To confirm the deletion map, FISH analysis of
metaphase chromosomes from patients 11 and 13 was
performed. Cosmids LLNc110-45O15 and ICRFc104-
A05122 were hybridized to metaphases from patient 11
and produced signals of normal intensity, whereas
ICRFc104-E10129 produced no signal. In patient 13,
YAC332B12, YAC924P6, RPCI1-118G17, LLNc110-
21L7, LLNc110-21J18, and ICRFc104-H09154 pro-
duced no signal, LLNc110-45O15 produced a weak sig-
nal, and ICRFc104-A05122 and ICRFc104-E10129
were fully preserved. Because of chimerism, YAC 903F3
was not used as a FISH probe.
Exon Trapping, Genomic Sequencing, and Isolation of
the Candidate Gene for MRX
By means of exon trapping on two cosmid clones
(LLNc110-45O15 and ICRFc104-A05122), eight pu-
tative exons were isolated. At the same time, 128 kb of
these cosmid clones were sequenced. The genomic region
between 40BT and K6 was subjected to sequence anal-
ysis with the NIX analysis software package. Two of the
previously trapped exons, KE14 and KO4, also were
identified by the exon-prediction programs; KO4 and
KE14 likely were trapped because of cryptic splice sites.
On the basis of the genomic sequence data (DDBJ/
EMBL/GenBank accession number AJ243947), PCR
primers for K7-2, K2H, K6, and K5 were established,
and they were tested on patients 11 and 13. The MRX
critical region was finally narrowed to an interval of15
kb between K7-2 and K2H (fig. 2B). Both trapped exon
clones, KE14 and KO4, reside within this minimal crit-
ical region.
RT-PCR experiments carried out on RNA from adult
testis subsequently showed that KO4 and KE14 are part
of a single gene encoding a predicted protein of 186
amino acids. The protein was enriched in serine, proline,
and glutamine residues and did not present any known
motifs. Exon I contains the putative start codon at po-
sition 147, exon II the first in-frame stop codon at nu-
cleotide 704 and a polyadenylation signal at position
824. The VCX-A gene has a genomic size of 1,019 bp.
Exon II contains a 30-bp repeat unit termed “RU1,”
which is present, in variable numbers, in individualswith
normal intelligence (see fig. 3B). Analyzing 50 unrelated
white male patients, we found that 39 (78%) of them
have 10 repeat units, 9 (18%) have 8 repeat units, 1
(2%) has 11 repeat units, and 1 (2%) has 12 repeat
units.
The VCX Gene Family: Structural Features and
Expression Profile
The genomic sequence revealed that the entire gene is
located on the sex chromosome–specific low-copy re-
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Figure 1 Deletion map and mental status of 15 patients. In the “MR” column, a plus sign () denotes mental retardation, and
a minus sign () denotes normal intelligence. Sequence-tagged-site loci are shown in black, gene loci are shown in red. The RPS6KA3
gene is thought to reside proximal to DXS85 and is not depicted on this map. The blackened portions of the horizontal bars represent
positive loci confirmed by molecular studies, and the unblackened portions represent absent loci. The physical locus order is based on
published reports (Schaefer et al. 1993; van Slegtenhorst et al. 1994; Ferrero et al. 1995; Herrell et al. 1995), with one exception—the
locus order of DXS6834 and DXS1139 is based on the physical map established in the present study. The underlined loci indicate the
boundaries of the critical region of the gene for MRX.
petitive element CRI-S232A (Li et al. 1992). The
BLASTN 2.0 homology-search program detected high
homology between this gene and VCY, previously
known as putative DNA- or RNA-binding protein
BPY1. VCY (BPY1) was isolated by cDNA selection on
cosmids randomly selected from the LLN0YC03 “M”
Y-chromosome cosmid library (Lahn and Page 1997).
Since, on the nucleotide level, this gene is 97% identical
to VCY, we termed it “VCX-A” (variably charged X
chromosome mRNA on CRI-S232A). In contrast to
VCY, which has only one 30-bp repeat unit in exon II,
VCX-A was observed to have 8 repeat units in the cos-
mid sequence (fig. 4).
CRI-S232 (DXS278) is known to have at least four
copies on the human X chromosome and to have two
on the Y chromosome (Li et al. 1992). Each CRI-S232
unit contains a 5-kb unique sequence in addition to two
elements, RU1 and RU2, composed of a variable number
of tandem repeats (VNTR) (fig. 3B). To isolate the para-
logues of VCX-A and to compare the different members
with one another, we investigated clones containing
other CRI-S232 sequences (proximal to VCX-A). VCX-
B and -C were isolated from physically mapped YAC
NB2E11 and BAC GS-478I2 clones, respectively, by
PCR primers (i.e., VCX EI [forward] and VCX EII
[reverse]) established from VCX-A (Ferrero et al. 1995).
The sequence of VCX-B1 was derived from a BAC
clone, GSHB-214D18, from The Genome Database.
One copy of VCY—VCY-D—is located on CRI-S232D,
which is contained within BAC clones NH0292P09
and NH0264A13. The other copy on the Y chromo-
some—VCY-E—was found in CRI-S232E, which is con-
tained within BAC clone NH0053K10 published by The
Genome Database. Family members VCX-A, -B1, -B,
and -C all reside within an interval of ∼2.5 Mb on
Xp22.3 (with one member distal and three members
proximal to the STS gene); VCY-D and VCY-E reside
within an interval of ∼50 kb on Yq11.2 (Ballabio et al.
1990; Bardoni et al. 1991; Herrell et al. 1995; Nelson
et al. 1995; Lahn and Page 1997).
Genomic analysis revealed that all family members
have a very similar exon/intron organization (fig. 4). In
addition, all members of the VCX-gene family are highly
homologous to each other, except for the number of
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Figure 2 Physical map and detailed deletion map of patients 11
and 13. A, Physical maps outlining the relationship between chromo-
somal markers, the clone contig, and DNA deletions in patients 11 and
13. Solid lines represent YAC clones (Ferrero et al. 1995), double lines
cosmid clones, and the dotted line a PAC clone. The names of PACs
and cosmid clones are as follows: 118G17, RPCI1-118G17; 21L7,
LLNc110-21L7; 21J18, LLNc110-21J18; H09154, ICRFc104-H09154;
45O15, LLNc110-45O15; A05122, ICRFc104-A05122; and E10129,
ICRFc104-E10129. Black dots represent positive markers in the respec-
tive clones. Cosmids 45O15 andA05122 overlap. “11” and“13”denote
cases 11 and 13, respectively. The blackened portions of the horizontal
bars represent loci that are present, unblackened portions represent ab-
sent loci, and gray-shaded portions represent the breakpoint region. Un-
derlined loci indicate the borders of theMRX critical region.B,Diagram
presenting the MRX critical interval (as defined by individuals 11 and
13) flanked by markers 40BT and DXS1139 (shown in boldface), which
reside on two overlapping cosmids. Deletion intervals in cases 11 and
13 are indicated. Black dots represent sequence-tagged sites established
on the basis of the genomic sequence data, and gray rectangles represent
trapped putative exons. Genomic sequencing was carried out between
markers 40BT and K6 (28 kb in total). The position of the trapped
putative exons was established on the basis of the genomic sequence.
repeat units in exon II (fig. 4). A VNTR is detectedwithin
all X-chromosome copies (VCX-A, -B, -B1, and -C),
whereas VCY-D and -E consistently have one repeat unit
(fig. 4). In a recent paper (Lahn and Page 2000), VCX-
A has been found to correspond to VCX-8r, VCX-B to
VCX-2r, andVCX-B1 toVCX-10r; VCX-C has not been
described prior to the present study.
To assess the pattern of expression, northern-blot
analysis and RT-PCR were carried out. When VCX-A
cDNA was used as a probe, a strong signal of ∼1.0 kb
was detected in adult testis; no signals were observed in
the other tissues tested (fig. 5). Subsequent RT-PCR ex-
periments in various fetal and adult tissues (fetal tis-
sues—muscle, heart, kidney, brain, and testis; adult tis-
sues—placenta, stomach, liver, muscle, heart, kidney,
brain, thalamus, hippocampus, and caudate nucleus) did
not reveal any expression at standard PCR conditions
(data not shown), suggesting that there is apparently
exclusive expression in adult testis tissue.
Discussion
We have defined a small MRX critical region by deletion
mapping of patients with chromosomal rearrangements
on Xp22.3 and with clinical features of a contiguous
gene–deletion syndrome. This was made possible by
comparison of small overlaps in two patients with de-
letion who had normal intelligence and who therefore
were expected to harbor an intact gene for cognitive
function. Genomic sequence analysis as well as exon
trapping revealed VCX-A as the only gene residing in
the defined critical interval (fig. 3A). The proximal bor-
der of this interval (K2H) was established on the basis
of data from several patients (cases 7–12 and 88), as
well as from most of the reported patients with XLI
(Ballabio et al. 1989; Shapiro et al. 1989; Schnur et al.
1990; Yen et al. 1990), whereas the distal border (K7-
2) is based on PCR and FISH analysis of only one patient
(case 13), a postgraduate student with high intelligence.
We were asking whether this patient has further DNA
distal to the critical region, yet the results of FISH anal-
ysis with Xp22.3-specific YACs, PACs, and cosmid
clones argue against this.
We have shown that VCX-A is preserved in all in-
dividuals with normal intelligence but is deleted in pa-
tients with Xp22.3 rearrangements and mental retar-
dation (fig. 3A). These results suggest that one intact
copy of VCX-A is sufficient to maintain normal mental
development. There is no correlation between the pres-
ence or absence of VCX-B, -B1, and -C and the mental
status of our patients. The finding that repeat elements
in CRI-S232A and -B contain VCX-A and VCX-B also
reveals that steroid sulfatase deficiency results from un-
equal crossover between the VCX-A gene (which re-
mains preserved) and the VCX-B gene (which is inter-
rupted), which flank the steroid sulfatase gene.
To further determine the role of VCX-A in cognitive
function and to explain the normal IQ in patients 13
and 511, who had deletion of VCX-B1, -B, and -C,
Figure 3 A, Refined deletion map indicating the region between markers DXS6837 and KAL. The position of VCX-A, -B1, -B, and -C
is shown in red. For the VCX-C locus, marker DXS1134 was tested. Cases are as depicted in figure 1. Blackened portions of the horizontal
bars represent loci present in the respective cases, and unblackened portions represent absent loci. B, Sequence organization of the CRI-S232
element, modified from that reported by Li et al. (1992). All instances of CRI-S232 share a very similar structure. The size of CRI-S232 is
variable between individuals, covers ∼7 kb of DNA, and is not drawn to scale. CRI-S232 is divided into four regions by EcoRI, XmnI, Bgl II,
and SstI. Regions b and c contain different repeat units. The VCX cDNA is 1,019 bp long, divided into two exons, and not drawn to scale.
Repeat unit RU1 is contained within the translated portion of exon II. VCX is located in regions b–d. The arrowheads below the VCX exons
indicate primers used to amplify the exons. The long arrows below the arrowheads represent the DNA interval that was sequenced in the
present study, except for the unstable RU2 repeat unit of !2 kb. The GenBank accession number for the genomic sequence is AJ243947 (GenBank
Overview).
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Figure 4 A, DNA sequence comparison of different members of the VCX and VCY family. Gray-shaded portions of the horizontal bars
represent exons, and the colored portions within exon II represent the 30-bp repeat units. In VCX-A, the number of repeat units is 8–12, on
the basis of data on 50 control males investigated in the present study. In three individuals, 10, 12, and 14 repeat units were detected in VCX-
C. The percentages indicate the degree of similarity between VCX-A and other VCX-family members. B, Amino acid comparison of members
of the VCX family. Red, pink, green, and light blue represent the specific 10-amino-acid (30-bp) repeats schematically outlined in figure 5A.
Differing amino acids are shown in dark blue.
expression profiles of the individual genes were analyzed
by RT-PCR. Expression at detectable levels was found
only in testicular tissue in allVCXmembers investigated
and was not detected in any of the postnatal brain struc-
tures analyzed. The apparent absence of VCX-A ex-
pression is not easy to reconcile with a putative cognitive
function, since most genes involved in mental retarda-
tion have been shown to be expressed in postnatal brain
structures—for example, in the cerebral cortex and hip-
pocampus; however, this may suggest that VCX-A has
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Figure 5 Expression study by northern analysis. The 1.0-kb sig-
nal in testis was revealed after overnight exposure. The hybridiza-
tion probe does not distinguish among the various members of the
VCX/-Y family.
a highly distinctive spatial and temporal expression pat-
tern, with elevated expression occurring only during
specific stages of neuronal development. In support of
this notion, among X-Y homologous genes the Y-linked
genes are usually expressed only in testis, whereas the
X-linked genes are shown to be expressed in a range of
tissues (Lahn and Page 1997).
To demonstrate a possible involvement of VCX-A in
the physiology of the CNS, mutation analysis was car-
ried out in five index patients with MRX (MRX21,
MRX24, MRX36, MRX37, and MRX49) whose fam-
ilies showed linkage to Xp22, to the region including
the VCX-A, -B1, and -B genes (Kozak et al. 1993; Mar-
tinez et al. 1995; Bar-David et al. 1996; Claes et al.
1996, 1997). Unfortunately, the genetic intervals of all
five pedigrees are quite large. The smallest genetically
defined region was for MRX49, spanning ∼15 Mb of
DNA, and the largest was for MRX21, spanning ∼38
Mb of DNA. Sequence analysis of all five index patients
failed to detect any mutation in the VCX genes.
The fascinating question of what differentiates us from
our closest mammalian relatives provokes thoughts re-
garding the quality (regulation) and quantity (number)
of genes with a putative involvement in cognitive func-
tion. Our finding that orthologues of VCX-A exist in
primates and in old- and new-world monkeys but not in
prosimians, marsupials, and other mammals (data not
shown) suggests that VCX originated ∼40 million years
ago. This occurred just after the separation of the pro-
simian and the higher-primate lineages. VCX was then
amplified rapidly during the evolution of the hominoids.
In addition to the amplification of the entire locus, the
30-bp gene internal repeat unit has been amplified up to
14 times. The discovery of a multiple 30-bp (10-amino-
acid) repeat unit predicted to be highly negatively charged
also raises the question of whether the expansion of these
repeats above a certain threshold may lead to disease. So
far, all known expansion diseases are considered to be
neurological in a broad sense, involving mostly triplets
or 12-bp expansions (Mandel 1997). Further investiga-
tions of theVCX-gene family, with regard to neurological
diseases and sex-chromosome evolution, are warranted.
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